Related Experiment Video
Updated: Aug 9, 2026
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 19, 2013
Enzyme-linked immunosorbent assay in screening of leukemia-associated nuclear proteins
M Rogalińska1, J Błoński, T Robak
1Department of Cytobiochemistry, University of Łódz, Banacha 12/16, 90-237 Łódz, Poland.
Insights
Researchers identified unique nuclear proteins in B-cell chronic lymphocytic leukemia (B-CLL) patients. These specific proteins, found in leukemic cells but not healthy donors, offer potential diagnostic markers for B-CLL.
Area of Science:
- Biochemistry
- Immunology
- Oncology
Background:
- Previous studies noted electrophoretic differences in nuclear proteins from B-cell chronic lymphocytic leukemia (B-CLL) patients' peripheral blood mononuclear cells.
- Nuclear non-histone proteins exhibit distinct characteristics between B-CLL patients and healthy individuals.
Purpose of the Study:
- To identify and characterize specific nuclear proteins in B-CLL.
- To develop diagnostic tools for B-CLL detection using these unique proteins.
Main Methods:
- Production of rabbit antisera against specific nuclear non-histone proteins (38/39 kDa and 44/46 kDa) from leukemic cells.
- Western blot analysis to confirm the presence of these proteins in B-CLL cells versus healthy cells.
- Enzyme-linked immunosorbent assay (ELISA) to quantify protein expression and assess cross-reactivity.
Main Results:
- Two specific nuclear non-histone proteins were identified in B-CLL mononuclear cells, absent in healthy donors.
- Western blot confirmed exclusive expression of these proteins in B-CLL patient cells.
- ELISA demonstrated significantly higher reactivity of B-CLL nuclear fractions compared to normal cell fractions with the generated antisera.
Conclusions:
- The identified nuclear proteins are specific biomarkers for B-cell chronic lymphocytic leukemia.
- These proteins show potential for developing sensitive diagnostic assays for B-CLL.
- The distinct reactivity patterns support their utility in distinguishing between leukemic and normal cells.
Abstract:
Our previous data revealed some diversities in electrophoretic characteristics of nuclear fraction proteins isolated from peripheral blood mononuclear cells of B-cell chronic lymphocytic leukemia (B-CLL) patients and healthy donors. Two electrophoretically-specific nuclear non-histones in the molecular mass zone of 38/39 and 44/46 kDa of leukemic mononuclear cells were used as immunogens to produce rabbit antisera. The Western blot analysis indicated that both nuclear components are expressed only in mononuclear cells isolated from peripheral blood of B-CLL patients, but not in those isolated from the blood of healthy donors. For further investigations of nuclear fraction from normal and B-CLL mononuclear cells, an enzyme-linked immunosorbent assay (ELISA) was used. The results obtained by ELISA with the antisera raised against both electrophoretically-specific B-CLL nuclear polypeptides revealed a different extend of cross-reactivity of nuclear fraction preparations isolated from normal cells and those isolated from leukemic ones. We noticed that nuclear fraction preparations which originated from leukemic mononuclear cells are much more reactive than normal ones with both antisera (at a broad range of antisera dilutions).
